Superior Cerebrovascular Outcomes with Tirzepatide versus Semaglutide in Diabetic Patients
A study comparing Tirzepatide to Semaglutide in diabetic CABG patients found significant benefits for cerebrovascular and cardiovascular outcomes, reducing mortality and complications.
Beyond weight loss- tirzepatide as a dual GIP:GLP-1 receptor agonist for obstruc
Tirzepatide, a dual GIP/GLP-1 receptor agonist, has been FDA-approved for treating moderate-to-severe OSA in obese adults. It significantly reduces AHI and improves sleep quality.
Dysesthesia associated with GLP-1 agonist therapies- data-mining analysis
A study reveals that GLP-1 agonists like semaglutide are linked to significant signals for hyperesthesia, dysesthesia, and burning sensation. These reactions are dose-dependent and can recur upon rechallenge.
Short-term effect of tirzepatide on serum calcitonin in adults with obesity
Tirzepatide treatment for 12 weeks resulted in a modest increase in serum calcitonin levels, remaining within normal ranges and showing no clinically relevant thyroid abnormalities.
GLP-1 Receptor Agonists Reduce Colorectal Cancer Risk
GLP-1 Clinical Relevance #47Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News | CED Clinic CommentaryObservational EvidenceColorectal Cancer PreventionGLP-1 Receptor…
GLP-1 Weight Loss: Clinical Evidence and Outcomes
GLP-1 Clinical Relevance #47Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News | CED Clinic NewsTelehealth Platform ExpansionWeight Loss ManagementGLP-1 Receptor AgonistPrimary…
GLP-1 Tirzepatide Cardiovascular Outcomes Clinical Evidence
GLP-1 Clinical Relevance #52Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News | CED Clinic Clinical NewsCardiovascular Outcomes StudyType 2 Diabetes…
GLP-1 Receptor Agonist Randomized Trial Evidence
GLP-1 Clinical Relevance #30Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic Clinical CommentaryObservational Evidence ReviewGLP-1 Receptor…
SEO Title (58 characters): GLP-1 Receptor Agonist Randomized Trial: Weight Loss Evidence
GLP-1 Clinical Relevance #30Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic CommentaryGLP-1 Receptor AgonistWeight LossSemaglutideFamily MedicineAdults with ObesityWeight…
Tirzepatide Cardiovascular Safety: Clinical Trial Evidence
GLP-1 Clinical Relevance #30Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic Clinical ReviewComparative Efficacy StudyCardiovascular OutcomesTirzepatideEndocrinologyAdults…